賽昂生醫武裝型T細胞 (Armed-T) 治療平台

賽昂生醫開創T細胞癌症治療突破性發展

CytoArm’s innovative BsAb Armed-T therapy platform utilizes non-viral bi-functional antibodies (BsAb) to empower T cells in targeting tumor cells effectively. This pioneering approach enables adaptable cancer treatments across various oncological conditions, potentially addressing limitless diseases

賽昂生醫的非病毒武裝型T細胞 (BsAb Armed-T) 平台：對抗超過50種疾病的專一性癌症治療